In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.

NeuroScientific Biopharmaceuticals Limited Balance Sheet Statement - Assets

As of 30 Jun 2023, The total current assets of NeuroScientific Biopharmaceuticals Limited (ASX:NSB) was around $- which consisted of no Cash, no Inventory and no Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.

All amounts in AUD

Cash
$-
Current assets
$-
Total assets
$-

The latest balance sheet of NeuroScientific Biopharmaceuticals Limited also showed no Property Plant Equipment and no Good will. Also there were no Intangible assets and no Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $-.

NeuroScientific Biopharmaceuticals Limited Balance Sheet Statement - Liabilities

NSB's latest annual results shows the balance sheet has no Accounts Payable. Also there were no Short/Long term debt, no Long term debt, no Other Current liabilities and no Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.

Account payable
$-
Current liabilities
$-
Total liabilities
$-

As per the 30 Jun 2023's annual report of NeuroScientific Biopharmaceuticals Limited, the total liabilities were $-.

NSB Balance Sheet Statement - Stock Holder Equity

Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.

The latest Balance sheet of NeuroScientific Biopharmaceuticals Limited showed the total stock holder equity was $- which consisted of no Common stocks, no Retained earnings and no Other stock holder equity.

NSB Balance Sheet Statement History

Following table shows the history of balance sheet for NeuroScientific Biopharmaceuticals Limited (NSB).

30 Jun 2023 30 Jun 2022 30 Jun 2021 30 Jun 2020
Cash - - - -
Net Receivables - - - -
Inventory - - - -
Total Current Assets - - - -
Property Plant Equipment - - - -
Good Will - - - -
Intangible Assets - - - -
Other Assets - - - -
Deferred Long Term Asset Charges - - - -
Total Assets - - - -
Accounts Payable - - - -
Short/Long Term Debt - - - -
Other Current Liabilities - - - -
Long Term Debt - - - -
Other Liabilities - - - -
Total Current Liabilities - - - -
Total Liabilities - - - -
Common Stock - - - -
Retained Earnings - - - -
Treasury Stock - - - -
Other Stockholder Equity - - - -
Total Stockholder Equity - - - -
Net Tangible Assets - - - -

NeuroScientific Biopharmaceuticals Limited (ASX:NSB) Balance Sheet Statement FAQ

1. How much Cash NeuroScientific Biopharmaceuticals Limited has on their balance sheet?

As of 30 Jun 2023, NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has no Cash.

2. What's the long term debt of NeuroScientific Biopharmaceuticals Limited?

As per the latest Balance sheet of NeuroScientific Biopharmaceuticals Limited (ASX:NSB), it has no Long term debt.

3. How much share holder equity does NeuroScientific Biopharmaceuticals Limited has?

The NeuroScientific Biopharmaceuticals Limited (ASX:NSB)'s balance sheet shows that it has no Total stock holder equity.